Role and regulation of MKP-1 in airway inflammation

Abstract Mitogen-activated protein kinase (MAPK) phosphatase 1 (MKP-1) is a protein with anti-inflammatory properties and the archetypal member of the dual-specificity phosphatases (DUSPs) family that have emerged over the past decade as playing an instrumental role in the regulation of airway infla...

Full description

Bibliographic Details
Main Authors: Seyed M. Moosavi, Pavan Prabhala, Alaina J. Ammit
Format: Article
Language:English
Published: BMC 2017-08-01
Series:Respiratory Research
Online Access:http://link.springer.com/article/10.1186/s12931-017-0637-3
_version_ 1818555546088767488
author Seyed M. Moosavi
Pavan Prabhala
Alaina J. Ammit
author_facet Seyed M. Moosavi
Pavan Prabhala
Alaina J. Ammit
author_sort Seyed M. Moosavi
collection DOAJ
description Abstract Mitogen-activated protein kinase (MAPK) phosphatase 1 (MKP-1) is a protein with anti-inflammatory properties and the archetypal member of the dual-specificity phosphatases (DUSPs) family that have emerged over the past decade as playing an instrumental role in the regulation of airway inflammation. Not only does MKP-1 serve a critical role as a negative feedback effector, controlling the extent and duration of pro-inflammatory MAPK signalling in airway cells, upregulation of this endogenous phosphatase has also emerged as being one of the key cellular mechanism responsible for the beneficial actions of clinically-used respiratory medicines, including β2-agonists, phosphodiesterase inhibitors and corticosteroids. Herein, we review the role and regulation of MKP-1 in the context of airway inflammation. We initially outline the structure and biochemistry of MKP-1 and summarise the multi-layered molecular mechanisms responsible for MKP-1 production more generally. We then focus in on some of the key in vitro studies in cell types relevant to airway disease that explain how MKP-1 can be regulated in airway inflammation at the transcriptional, post-translation and post-translational level. And finally, we address some of the potential challenges with MKP-1 upregulation that need to be explored further to fully exploit the potential of MKP-1 to repress airway inflammation in chronic respiratory disease.
first_indexed 2024-12-12T09:54:51Z
format Article
id doaj.art-747b035e55cf4b9aa17afa8890e88c66
institution Directory Open Access Journal
issn 1465-993X
language English
last_indexed 2024-12-12T09:54:51Z
publishDate 2017-08-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj.art-747b035e55cf4b9aa17afa8890e88c662022-12-22T00:28:10ZengBMCRespiratory Research1465-993X2017-08-0118111210.1186/s12931-017-0637-3Role and regulation of MKP-1 in airway inflammationSeyed M. Moosavi0Pavan Prabhala1Alaina J. Ammit2School of Life Sciences, University of Technology SydneyDepartment of Molecular Pharmacology, University of GroningenSchool of Life Sciences, University of Technology SydneyAbstract Mitogen-activated protein kinase (MAPK) phosphatase 1 (MKP-1) is a protein with anti-inflammatory properties and the archetypal member of the dual-specificity phosphatases (DUSPs) family that have emerged over the past decade as playing an instrumental role in the regulation of airway inflammation. Not only does MKP-1 serve a critical role as a negative feedback effector, controlling the extent and duration of pro-inflammatory MAPK signalling in airway cells, upregulation of this endogenous phosphatase has also emerged as being one of the key cellular mechanism responsible for the beneficial actions of clinically-used respiratory medicines, including β2-agonists, phosphodiesterase inhibitors and corticosteroids. Herein, we review the role and regulation of MKP-1 in the context of airway inflammation. We initially outline the structure and biochemistry of MKP-1 and summarise the multi-layered molecular mechanisms responsible for MKP-1 production more generally. We then focus in on some of the key in vitro studies in cell types relevant to airway disease that explain how MKP-1 can be regulated in airway inflammation at the transcriptional, post-translation and post-translational level. And finally, we address some of the potential challenges with MKP-1 upregulation that need to be explored further to fully exploit the potential of MKP-1 to repress airway inflammation in chronic respiratory disease.http://link.springer.com/article/10.1186/s12931-017-0637-3
spellingShingle Seyed M. Moosavi
Pavan Prabhala
Alaina J. Ammit
Role and regulation of MKP-1 in airway inflammation
Respiratory Research
title Role and regulation of MKP-1 in airway inflammation
title_full Role and regulation of MKP-1 in airway inflammation
title_fullStr Role and regulation of MKP-1 in airway inflammation
title_full_unstemmed Role and regulation of MKP-1 in airway inflammation
title_short Role and regulation of MKP-1 in airway inflammation
title_sort role and regulation of mkp 1 in airway inflammation
url http://link.springer.com/article/10.1186/s12931-017-0637-3
work_keys_str_mv AT seyedmmoosavi roleandregulationofmkp1inairwayinflammation
AT pavanprabhala roleandregulationofmkp1inairwayinflammation
AT alainajammit roleandregulationofmkp1inairwayinflammation